Oral candidiasis primary prevention: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Good [[oral hygiene]] practices may help to prevent [[Oral thrush|oral thrush]] in people with [[immunosuppression]]. Some studies have shown that [[chlorhexidine]] (CHX) mouthwash can help to prevent oral candidiasis in people | Good [[oral hygiene]] practices may help to prevent [[Oral thrush|oral thrush]] in people with [[immunosuppression]]. Some studies have shown that [[chlorhexidine]] (CHX) mouthwash can help to prevent oral candidiasis in people undergoing [[cancer]] treatment. People who use inhaled [[corticosteroids]] may be able to reduce the risk of developing thrush by washing out the mouth with water or mouthwash after using an inhaler. | ||
==Primary prevention== | ==Primary prevention== | ||
*Some studies have shown that [[chlorhexidine]] (CHX) mouthwash can help to prevent oral candidiasis in people | *Some studies have shown that [[chlorhexidine]] (CHX) mouthwash can help to prevent oral candidiasis in people undergoing [[cancer]] treatment. | ||
*People who use inhaled [[corticosteroids]] may be able | *People who use inhaled [[corticosteroids]] may be able to reduce the risk of developing thrush by washing out the mouth with water or mouthwash after using an inhaler. | ||
*Continuous prophylactic [[fluconazole]] use is more effective than intermittent use in response to relapses.<ref name="pmid19191635">{{cite journal| author=Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE et al.| title=Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | journal=Clin Infect Dis | year= 2009 | volume= 48 | issue= 5 | pages= 503-35 | pmid=19191635 | doi=10.1086/596757 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19191635 }} </ref> | *Continuous prophylactic [[fluconazole]] use is more effective than intermittent use in response to relapses.<ref name="pmid19191635">{{cite journal| author=Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE et al.| title=Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | journal=Clin Infect Dis | year= 2009 | volume= 48 | issue= 5 | pages= 503-35 | pmid=19191635 | doi=10.1086/596757 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19191635 }} </ref> | ||
Revision as of 16:03, 11 May 2017
Oral candidiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oral candidiasis primary prevention On the Web |
American Roentgen Ray Society Images of Oral candidiasis primary prevention |
Risk calculators and risk factors for Oral candidiasis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Good oral hygiene practices may help to prevent oral thrush in people with immunosuppression. Some studies have shown that chlorhexidine (CHX) mouthwash can help to prevent oral candidiasis in people undergoing cancer treatment. People who use inhaled corticosteroids may be able to reduce the risk of developing thrush by washing out the mouth with water or mouthwash after using an inhaler.
Primary prevention
- Some studies have shown that chlorhexidine (CHX) mouthwash can help to prevent oral candidiasis in people undergoing cancer treatment.
- People who use inhaled corticosteroids may be able to reduce the risk of developing thrush by washing out the mouth with water or mouthwash after using an inhaler.
- Continuous prophylactic fluconazole use is more effective than intermittent use in response to relapses.[1]
References
- ↑ Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE; et al. (2009). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clin Infect Dis. 48 (5): 503–35. doi:10.1086/596757. PMID 19191635.